Lower open after yesterday's record session

The markets opened lower with the Dow losing 38 points to 16,904 after a record session yesterday. Nasdaq slipped 9 points to 4,326.

On the upside

Achillion Pharmaceuticals (Nasdaq: ACHN) initiated dosing of patients in a Phase 1 clinical trial of its hepatitis C treatment ACH-3422 and announced the lifting of a clinical hold on another hepatitis C drug sovaprevir.

Receptos (Nasdaq: RCPT) reported positive results from a Phase 2 study of its relapsing multiple sclerosis treatment RPC1063.

Financial Times reported that Chico's FAS (NYSE: CHS) has engaged in discussions to go private.

On the downside

Francesca's Holdings (Nasdaq: FRAN) disappointed with lower first quarter earnings that missed expectations, forecast second quarter results below estimates and lowered its full year outlook.

RadioShack (NYSE: RSH) widened losses more than expected as revenue dropped.

B/E Aerospace (Nasdaq: BEAV) will separate into two independent publicly traded companies.

In the broad market, declining issues outpaced advancers by a margin of more than 9 to 7 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 lost 5 points to 1946. Bitcoin added $4.52 or 0.69% to $650.17.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here